Cost and Value in Contemporary Heart Failure Clinical Guidance Documents
John W. Ostrominski(Brigham and Women's Hospital), Muthiah Vaduganathan(Brigham and Women's Hospital), Paul A. Heidenreich(Palo Alto University), Thomas M. Maddox(BJC HealthCare), James L. Januzzi(Harvard University), Mona Fiuzat(Duke University), Ankeet S. Bhatt(Kaiser Permanente San Francisco Medical Center), Carolyn S.P. Lam(University of Glasgow), Gregg C. Fonarow(UCLA Medical Center), Sameer Hirji(Harvard University), Christopher M. O’Connor(Inova Health System), Javed Butler(Jackson Memorial Hospital)
Cited by 18
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Forecasting the Future of Cardiovascular Disease in the United States
|Circulation|2011|3.2k